metformin has been researched along with Diffuse Lymphocytic Lymphoma, Poorly-Differentiated in 3 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Schlesser, C | 1 |
| Meul, T | 1 |
| Stathopoulos, G | 1 |
| Meiners, S | 1 |
| Liu, Y | 1 |
| Kimpara, S | 1 |
| Hoang, NM | 1 |
| Daenthanasanmak, A | 1 |
| Li, Y | 1 |
| Lu, L | 1 |
| Ngo, VN | 1 |
| Bates, PD | 1 |
| Song, L | 1 |
| Gao, X | 1 |
| Bebel, S | 1 |
| Chen, M | 1 |
| Chen, R | 1 |
| Zhang, X | 1 |
| Selberg, PE | 1 |
| Kenkre, VP | 1 |
| Waldmann, TA | 1 |
| Capitini, CM | 1 |
| Rui, L | 1 |
| Dennison, JB | 1 |
| Ayres, ML | 1 |
| Kaluarachchi, K | 1 |
| Plunkett, W | 1 |
| Gandhi, V | 1 |
3 other studies available for metformin and Diffuse Lymphocytic Lymphoma, Poorly-Differentiated
| Article | Year |
|---|---|
Metformin Induces Resistance of Cancer Cells to the Proteasome Inhibitor Bortezomib.
Topics: Adult; Antineoplastic Agents; Antiviral Agents; Boronic Acids; Bortezomib; Carcinoma, Non-Small-Cell | 2022 |
EGR1-mediated metabolic reprogramming to oxidative phosphorylation contributes to ibrutinib resistance in B-cell lymphoma.
Topics: Adult; Agammaglobulinaemia Tyrosine Kinase; Animals; Antineoplastic Agents; Cell Line, Tumor; Drug R | 2023 |
Intracellular succinylation of 8-chloroadenosine and its effect on fumarate levels.
Topics: 2-Chloroadenosine; 8-Bromo Cyclic Adenosine Monophosphate; Antineoplastic Agents; Cell Line, Tumor; | 2010 |